2015-2023 World Rare Disease Drug Market Research Report by Product Type, End-User (Application) and Regions (Countries)
SUMMARY
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Spain etc)
- Asia-Pacific (China, India, Japan, Southeast Asia etc)
- South America (Brazil, Argentina etc)
- Middle East & Africa (Saudi Arabia, South Africa etc)
- >1?
- 0.65??1?
- <0.1?
- Hospital Pharmacies
- Speciality Pharmacies
- Retail pharmacies
- Others
- Novartis AG
- Bristol-Myers Squibb Company
- Celgene Corporation
- F. Hoffmann-La Roche Ltd.
- Pfizer, Inc.
- Sanofi S.A.
- Alexion Pharmaceuticals, Inc.
- Eli Lilly and Company
- Novo Nordisk A/S
- AstraZeneca
- Eisai Co., Ltd.
- Daiichi Sankyo Company Limited
- Bayer AG
- GlaxoSmithKline
- Merck & Co., Inc.
- Johnson & Johnson
- Biogen, Inc.
- Shire
- Amgen, Inc.
- Deciphera
- Atara Biotherapeutics
- ProQR
1 MARKET DEFINITION
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use/Application
2 GLOBAL MARKET BY VENDORS
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 GLOBAL MARKET BY TYPE
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 GLOBAL MARKET BY END-USE/APPLICATION
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 GLOBAL MARKET BY REGIONS
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 NORTH AMERICA MARKET
6.1 by Type
6.2 by End-Use/Application
6.3 by Regions
7 EUROPE MARKET
7.1 by Type
7.2 by End-Use/Application
7.3 by Regions
8 ASIA-PACIFIC MARKET
8.1 by Type
8.2 by End-Use/Application
8.3 by Regions
9 SOUTH AMERICA MARKET
9.1 by Type
9.2 by End-Use/Application
9.3 by Regions
10 MIDDLE EAST & AFRICA MARKET
10.1 by Type
10.2 by End-Use/Application
10.3 by Regions
11 MARKET FORECAST
11.1 Global Market Forecast (2018-2023)
11.2 Market Forecast by Regions (2018-2023)
11.3 Market Forecast by Type (2018-2023)
11.4 Market Forecast by End-Use/Application (2018-2023)
12 KEY MANUFACTURERS
12.1 Novartis AG
12.1.2 Company Overview
12.1.2 Product and End-User/Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Bristol-Myers Squibb Company
12.2.1 Company Overview
12.2.2 Product and End-User/Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Celgene Corporation
12.3.1 Company Overview
12.3.2 Product and End-User/Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 Company Overview
12.4.2 Product and End-User/Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Pfizer, Inc.
12.5.1 Company Overview
12.5.2 Product and End-User/Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Sanofi S.A.
12.12.1 Company Overview
12.12.2 Product and End-User/Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Alexion Pharmaceuticals, Inc.
12.7.1 Company Overview
12.7.2 Product and End-User/Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Eli Lilly and Company
12.8.1 Company Overview
12.8.2 Product and End-User/Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Novo Nordisk A/S
12.9.1 Company Overview
12.9.2 Product and End-User/Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 AstraZeneca
12.10.1 Company Overview
12.10.2 Product and End-User/Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Eisai Co., Ltd.
12.12 Daiichi Sankyo Company Limited
12.13 Bayer AG
12.14 GlaxoSmithKline
12.15 Merck & Co., Inc.
12.16 Johnson & Johnson
12.17 Biogen, Inc.
12.18 Shire
12.19 Amgen, Inc.
12.20 Deciphera
12.21 Atara Biotherapeutics
12.22 ProQR
9 RESEARCH CONCLUSION
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use/Application
2 GLOBAL MARKET BY VENDORS
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 GLOBAL MARKET BY TYPE
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 GLOBAL MARKET BY END-USE/APPLICATION
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 GLOBAL MARKET BY REGIONS
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 NORTH AMERICA MARKET
6.1 by Type
6.2 by End-Use/Application
6.3 by Regions
7 EUROPE MARKET
7.1 by Type
7.2 by End-Use/Application
7.3 by Regions
8 ASIA-PACIFIC MARKET
8.1 by Type
8.2 by End-Use/Application
8.3 by Regions
9 SOUTH AMERICA MARKET
9.1 by Type
9.2 by End-Use/Application
9.3 by Regions
10 MIDDLE EAST & AFRICA MARKET
10.1 by Type
10.2 by End-Use/Application
10.3 by Regions
11 MARKET FORECAST
11.1 Global Market Forecast (2018-2023)
11.2 Market Forecast by Regions (2018-2023)
11.3 Market Forecast by Type (2018-2023)
11.4 Market Forecast by End-Use/Application (2018-2023)
12 KEY MANUFACTURERS
12.1 Novartis AG
12.1.2 Company Overview
12.1.2 Product and End-User/Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Bristol-Myers Squibb Company
12.2.1 Company Overview
12.2.2 Product and End-User/Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Celgene Corporation
12.3.1 Company Overview
12.3.2 Product and End-User/Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 Company Overview
12.4.2 Product and End-User/Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Pfizer, Inc.
12.5.1 Company Overview
12.5.2 Product and End-User/Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Sanofi S.A.
12.12.1 Company Overview
12.12.2 Product and End-User/Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Alexion Pharmaceuticals, Inc.
12.7.1 Company Overview
12.7.2 Product and End-User/Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Eli Lilly and Company
12.8.1 Company Overview
12.8.2 Product and End-User/Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Novo Nordisk A/S
12.9.1 Company Overview
12.9.2 Product and End-User/Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 AstraZeneca
12.10.1 Company Overview
12.10.2 Product and End-User/Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Eisai Co., Ltd.
12.12 Daiichi Sankyo Company Limited
12.13 Bayer AG
12.14 GlaxoSmithKline
12.15 Merck & Co., Inc.
12.16 Johnson & Johnson
12.17 Biogen, Inc.
12.18 Shire
12.19 Amgen, Inc.
12.20 Deciphera
12.21 Atara Biotherapeutics
12.22 ProQR
9 RESEARCH CONCLUSION
LIST OF TABLES
Table Global Rare Disease Drug Market and Growth by Type
Table Global Rare Disease Drug Market and Growth by End-Use / Application
Table Global Rare Disease Drug Revenue (Million USD) by Vendors (2015-2017)
Table Global Healthcare & Medical Revenue Share by Vendors (2015-2017)
Table Global Rare Disease Drug Market Volume (Volume) by Vendors (2015-2017)
Table Global Rare Disease Drug Market Volume Share by Vendors (2015-2017)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table Global Rare Disease Drug Market Share by Type (2015-2017)
Table Global Rare Disease Drug Market Volume (Volume) by Type (2015-2017)
Table Global Rare Disease Drug Market Volume Share by Type (2015-2017)
Table Global Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table Global Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table Global Rare Disease Drug Market Volume (Volume) by End-Use / Application (2015-2017)
Table Global Rare Disease Drug Market Volume Share by End-Use / Application (2015-2017)
Table Global Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table Global Rare Disease Drug Market Share by Regions (2015-2017)
Table Global Rare Disease Drug Market Volume (Volume) by Regions (2015-2017)
Table Global Rare Disease Drug Market Volume Share by Regions (2015-2017)
Table North America Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table North America Rare Disease Drug Market Share by Type (2015-2017)
Table North America Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table North America Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table North America Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table North America Rare Disease Drug Market Share by Regions (2015-2017)
Table Europe Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table Europe Rare Disease Drug Market Share by Type (2015-2017)
Table Europe Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table Europe Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table Europe Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table Europe Rare Disease Drug Market Share by Regions (2015-2017)
Table Asia-Pacific Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table Asia-Pacific Rare Disease Drug Market Share by Type (2015-2017)
Table Asia-Pacific Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table Asia-Pacific Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table Asia-Pacific Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table Asia-Pacific Rare Disease Drug Market Share by Regions (2015-2017)
Table South America Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table South America Rare Disease Drug Market Share by Type (2015-2017)
Table South America Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table South America Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table South America Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table Middle East & Africa Rare Disease Drug Market Share by Regions (2015-2017)
Table Middle East & Africa Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table Middle East & Africa Rare Disease Drug Market Share by Type (2015-2017)
Table Middle East & Africa Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table Middle East & Africa Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table Middle East & Africa Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table Middle East & Africa Rare Disease Drug Market Share by Regions (2015-2017)
Table Global Rare Disease Drug Market (Million USD) Forecast by Regions (2018-2023)
Table Global Rare Disease Drug Market Share Forecast by Regions (2018-2023)
Table Global Rare Disease Drug Market Volume (Volume) Forecast by Regions (2018-2023)
Table Global Rare Disease Drug Market Volume Share Forecast by Regions (2018-2023)
Table Global Rare Disease Drug Market (Million USD) Forecast by Type (2018-2023)
Table Global Rare Disease DrugMarket Share by Forecast Type (2018-2023)
Table Global Rare Disease Drug Market (Million USD) Forecast by End-Use / Application (2018-2023)
Table Global Rare Disease Drug Market Share Forecast by End-Use / Application (2018-2023)
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb Company
Table Sales Revenue, Volume, Price, Cost and Margin of Celgene Corporation
Table Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi S.A.
Table Sales Revenue, Volume, Price, Cost and Margin of Alexion Pharmaceuticals, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly and Company
Table Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk A/S
Table Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Table Sales Revenue, Volume, Price, Cost and Margin of Eisai Co., Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo Company Limited
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer AG
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of Merck & Co., Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Volume, Price, Cost and Margin of Biogen, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Shire
Table Sales Revenue, Volume, Price, Cost and Margin of Amgen, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Deciphera
Table Sales Revenue, Volume, Price, Cost and Margin of Atara Biotherapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of ProQR
Table Global Rare Disease Drug Market and Growth by Type
Table Global Rare Disease Drug Market and Growth by End-Use / Application
Table Global Rare Disease Drug Revenue (Million USD) by Vendors (2015-2017)
Table Global Healthcare & Medical Revenue Share by Vendors (2015-2017)
Table Global Rare Disease Drug Market Volume (Volume) by Vendors (2015-2017)
Table Global Rare Disease Drug Market Volume Share by Vendors (2015-2017)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table Global Rare Disease Drug Market Share by Type (2015-2017)
Table Global Rare Disease Drug Market Volume (Volume) by Type (2015-2017)
Table Global Rare Disease Drug Market Volume Share by Type (2015-2017)
Table Global Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table Global Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table Global Rare Disease Drug Market Volume (Volume) by End-Use / Application (2015-2017)
Table Global Rare Disease Drug Market Volume Share by End-Use / Application (2015-2017)
Table Global Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table Global Rare Disease Drug Market Share by Regions (2015-2017)
Table Global Rare Disease Drug Market Volume (Volume) by Regions (2015-2017)
Table Global Rare Disease Drug Market Volume Share by Regions (2015-2017)
Table North America Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table North America Rare Disease Drug Market Share by Type (2015-2017)
Table North America Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table North America Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table North America Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table North America Rare Disease Drug Market Share by Regions (2015-2017)
Table Europe Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table Europe Rare Disease Drug Market Share by Type (2015-2017)
Table Europe Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table Europe Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table Europe Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table Europe Rare Disease Drug Market Share by Regions (2015-2017)
Table Asia-Pacific Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table Asia-Pacific Rare Disease Drug Market Share by Type (2015-2017)
Table Asia-Pacific Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table Asia-Pacific Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table Asia-Pacific Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table Asia-Pacific Rare Disease Drug Market Share by Regions (2015-2017)
Table South America Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table South America Rare Disease Drug Market Share by Type (2015-2017)
Table South America Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table South America Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table South America Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table Middle East & Africa Rare Disease Drug Market Share by Regions (2015-2017)
Table Middle East & Africa Rare Disease Drug Market (Million USD) by Type (2015-2017)
Table Middle East & Africa Rare Disease Drug Market Share by Type (2015-2017)
Table Middle East & Africa Rare Disease Drug Market (Million USD) by End-Use / Application (2015-2017)
Table Middle East & Africa Rare Disease Drug Market Share by End-Use / Application (2015-2017)
Table Middle East & Africa Rare Disease Drug Market (Million USD) by Regions (2015-2017)
Table Middle East & Africa Rare Disease Drug Market Share by Regions (2015-2017)
Table Global Rare Disease Drug Market (Million USD) Forecast by Regions (2018-2023)
Table Global Rare Disease Drug Market Share Forecast by Regions (2018-2023)
Table Global Rare Disease Drug Market Volume (Volume) Forecast by Regions (2018-2023)
Table Global Rare Disease Drug Market Volume Share Forecast by Regions (2018-2023)
Table Global Rare Disease Drug Market (Million USD) Forecast by Type (2018-2023)
Table Global Rare Disease DrugMarket Share by Forecast Type (2018-2023)
Table Global Rare Disease Drug Market (Million USD) Forecast by End-Use / Application (2018-2023)
Table Global Rare Disease Drug Market Share Forecast by End-Use / Application (2018-2023)
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb Company
Table Sales Revenue, Volume, Price, Cost and Margin of Celgene Corporation
Table Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi S.A.
Table Sales Revenue, Volume, Price, Cost and Margin of Alexion Pharmaceuticals, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly and Company
Table Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk A/S
Table Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Table Sales Revenue, Volume, Price, Cost and Margin of Eisai Co., Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo Company Limited
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer AG
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of Merck & Co., Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Volume, Price, Cost and Margin of Biogen, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Shire
Table Sales Revenue, Volume, Price, Cost and Margin of Amgen, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Deciphera
Table Sales Revenue, Volume, Price, Cost and Margin of Atara Biotherapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of ProQR
LIST OF FIGURES
Figure Global Rare Disease Drug Market Size (Million USD) 2012-2022
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2015-2017
Figure Asia-Pacific Market Growth 2015-2017
Figure South America Market Growth 2015-2017
Figure Middle East & Africa Market Growth 2015-2017
Figure Global Rare Disease Drug Market (Million USD) and Growth Forecast (2018-2023)
Figure Global Rare Disease Drug Market Volume (Volume) and Growth Forecast (2018-2023)
Figure Global Rare Disease Drug Market Size (Million USD) 2012-2022
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2015-2017
Figure Asia-Pacific Market Growth 2015-2017
Figure South America Market Growth 2015-2017
Figure Middle East & Africa Market Growth 2015-2017
Figure Global Rare Disease Drug Market (Million USD) and Growth Forecast (2018-2023)
Figure Global Rare Disease Drug Market Volume (Volume) and Growth Forecast (2018-2023)
